Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03ZFX
|
|||
Former ID |
DNC013564
|
|||
Drug Name |
D-254C
|
|||
Synonyms |
D-254C; CHEMBL258725; SCHEMBL4886148
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C27H32N2O
|
|||
Canonical SMILES |
C1CC(NCC1NCC(CC2=CC=CC=C2)O)C(C3=CC=CC=C3)C4=CC=CC=C4
|
|||
InChI |
1S/C27H32N2O/c30-25(18-21-10-4-1-5-11-21)20-28-24-16-17-26(29-19-24)27(22-12-6-2-7-13-22)23-14-8-3-9-15-23/h1-15,24-30H,16-20H2/t24-,25+,26-/m0/s1
|
|||
InChIKey |
YKFRXVGLZNKBAS-NXCFDTQHSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an ex... Bioorg Med Chem. 2008 Mar 15;16(6):2769-78. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.